Article Text

PDF
When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy
  1. Andrew Nicolson1,
  2. Anthony G Marson2
  1. 1Consultant Neurologist, The Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, UK
  2. 2Professor and Honorary Consultant Neurologist, The University of Liverpool, Division of Neurological Science, Clinical Sciences Centre for Research and Education, Fazakerley, Liverpool, UK
  1. Correspondence to Dr A Nicolson, The Walton Centre NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ, UK; andrew.nicolson{at}thewaltoncentre.nhs.uk

Abstract

Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic.

Statistics from Altmetric.com

Footnotes

  • Competing interests AN and AGM have received honoraria and/or hospitality from the pharmaceutical companies that manufacture all of the drugs discussed in this article.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.